Hussman Strategic Advisors, Inc. Invitae Corp Transaction History

Hussman Strategic Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	SELL	$11.71 - $30.29 $292,750 - $757,250	-25,000 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$7.64 - $27.5 $38,200 - $137,500	-5,000 Reduced 16.67%	25,000 $342,000
Q4 2019 Jan 31, 2020	SELL	$15.02 - $20.57 $450,600 - $617,100	-30,000 Reduced 50.0%	30,000 $484,000
Q3 2019 Oct 31, 2019	BUY	$18.85 - $27.5 $1.13 Million - $1.65 Million	60,000 New	60,000 $1.16 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.